ID   MM9H-1
AC   CVCL_C6JG
DR   CCRID; 4201PAT-CCTCC01838
DR   Wikidata; Q116049793
RX   Patent=CN113201494B;
RX   PubMed=35666052;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202174.
CC   Population: Chinese.
CC   Doubling time: ~36 hours (PubMed=35666052).
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
RX   Patent=CN113201494B;
RA   Shi C.-J., Gu Z.-Y., Zhou R., Xu S.-M., Han Y., Ren G.-X.,
RA   Zhang Z.-Z.;
RT   "Mucosal melanoma cell and application thereof.";
RL   Patent number CN113201494B, 21-Apr-2023.
//
RX   PubMed=35666052; DOI=10.1002/cac2.12315;
RA   Shi C.-J., Gu Z.-Y., Xu S.-M., Ju H.-Y., Wu Y.-T., Han Y., Li J.-Y.,
RA   Li C.-W., Wu J., Wang L.-Z., Li J., Zhou G.-Y., Ye W.-M., Ren G.-X.,
RA   Zhang Z.-Y., Zhou R.;
RT   "Candidate therapeutic agents in a newly established triple wild-type
RT   mucosal melanoma cell line.";
RL   Cancer Commun. (Lond.) 42:627-647(2022).
//